Variant report
Variant | esv3329661 |
---|---|
Chromosome Location | chr2:186505557-186507705 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150857846 | chr2:186505563-186505564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550448002 | chr2:186505631-186505632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188358857 | chr2:186505652-186505653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73033663 | chr2:186505659-186505660 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs193291444 | chr2:186505710-186505711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115896395 | chr2:186505726-186505727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185581039 | chr2:186505743-186505744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553096436 | chr2:186505871-186505872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555447743 | chr2:186505879-186505880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577717009 | chr2:186505890-186505891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373361104 | chr2:186505900-186505901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573957465 | chr2:186505910-186505911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538571691 | chr2:186505937-186505938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs78059358 | chr2:186505994-186505995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78900837 | chr2:186505995-186505996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71648869 | chr2:186506005-186506006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375311689 | chr2:186506023-186506024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538816121 | chr2:186506118-186506119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368096622 | chr2:186506136-186506137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35969705 | chr2:186506151-186506152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189143882 | chr2:186506247-186506248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61202376 | chr2:186506380-186506381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377701850 | chr2:186506384-186506385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34170483 | chr2:186506407-186506408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200303188 | chr2:186506487-186506488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565286401 | chr2:186506494-186506495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs137946654 | chr2:186506500-186506501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371544802 | chr2:186506516-186506517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180923960 | chr2:186506560-186506561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561566325 | chr2:186506572-186506573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71411134 | chr2:186506584-186506585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201964231 | chr2:186506585-186506586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549187201 | chr2:186506586-186506587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59786440 | chr2:186506587-186506588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60218955 | chr2:186506595-186506596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs60677985 | chr2:186506616-186506617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71014616 | chr2:186506619-186506620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112253481 | chr2:186506629-186506630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528852182 | chr2:186506660-186506661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183504567 | chr2:186506710-186506711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12992042 | chr2:186506730-186506731 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs532971289 | chr2:186506782-186506783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551129096 | chr2:186506844-186506845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542988093 | chr2:186506908-186506909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372319015 | chr2:186506916-186506917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13410805 | chr2:186506929-186506930 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs534061947 | chr2:186506943-186506944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188675191 | chr2:186506991-186506992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79162084 | chr2:186507006-186507007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538238393 | chr2:186507061-186507062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ependymoma | 20639864 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186503800-186508200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:186504200-186509000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr2:186505400-186508400 | Weak transcription | Fetal Stomach | stomach |
4 | chr2:186507000-186507200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr2:186507000-186510400 | Enhancers | Fetal Intestine Small | intestine |
6 | chr2:186507000-186511000 | Enhancers | Fetal Intestine Large | intestine |
7 | chr2:186507200-186508400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:186507600-186511200 | Enhancers | HepG2 | liver |